Advance in studies on long-circulating tumor targeted compound preparations.
- Author:
Qiu-Ping LI
;
Xiao-Man LIU
;
Jun-Dong DAI
- Publication Type:Journal Article
- MeSH:
Animals;
Antineoplastic Agents;
blood;
chemistry;
therapeutic use;
Drug Compounding;
methods;
Humans;
Molecular Targeted Therapy;
methods;
Neoplasms;
blood;
drug therapy
- From:
China Journal of Chinese Materia Medica
2014;39(3):402-406
- CountryChina
- Language:Chinese
-
Abstract:
Tumor has long been a hard-nut problem in the world medical field. The effect of the conventional drugs is very limited because of the intervention of multiple micro-environmental factors during the occurrence and progression of tumors. With the characteristics of high efficiency, low toxicity and multi-targets synergistic effect, the long-circulating tumor targeted compound preparations show its unique advantages in improving tumor microenvironment and enhancing the therapeutic effect of treatment, thus it has gradually become a hotspot of studies both at home and abroad. Through consulting a great number of professional literatures at home and abroad in recent years, the authors summarized the current studies in vitro and in vive on long-circulating tumor targeted compound preparations in different carriers, in the expectation of providing new ideas and methods for the development of long-circulating tumor targeted compound preparations.
